FDA Official Says One Death Reported Due To Blood Clot Event After J&J Vaccine

US recommends ‘pause’ for J&J shots in blow to vaccine drive

 

 

WASHINGTON (AP) — The U.S. on Tuesday recommended a “pause” in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccination campaign.

The Centers for Disease Control and Prevention and the Food and Drug Administration announced that they were investigating unusual clots in six women between the ages of 18 and 48. One person died. 

Government Database Shows 7,844 Injuries and 181 Deaths Following COVID Vaccine as of Jan. 15 says Children's Health Defense This could be the tip of the iceberg as studies of this database show... 

Last week, California health officials temporarily paused a large batch of Moderna vaccines due to a high number of allergic reactions, but reversed that decision a few days later. Anyone suffering from a serious injury will have little legal recourse because they will be directed to the Countermeasures Injury Compensation Program which has rejected 90% of vaccine-injury claims over the past decade.